Prairie Operating Co. (PROP)
NASDAQ: PROP · Real-Time Price · USD
0.8927
-0.0225 (-2.46%)
At close: May 29, 2026, 4:00 PM EDT
0.9000
+0.0073 (0.82%)
After-hours: May 29, 2026, 7:39 PM EDT
Company Description
Prairie Operating Co., an independent energy company, engages in the acquisition and development of crude oil, natural gas, and natural gas liquids resources in the United States. Prairie Operating Co. is based in Houston, Texas.
Prairie Operating Co.
| Country | United States |
| Founded | 2001 |
| Industry | Oil & Gas Exploration & Production |
| Sector | Energy |
| Employees | 59 |
| CEO | Richard Frommer |
Contact Details
Address: 55 Waugh Drive, Suite 400 Houston, Texas 77007 United States | |
| Phone | 713 766 1200 |
| Website | prairieopco.com |
Stock Details
| Ticker Symbol | PROP |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 1162896 |
| CUSIP Number | 739650109 |
| ISIN Number | US7396501097 |
| Employer ID | 98-0357690 |
| SIC Code | 1311 |
Key Executives
| Name | Position |
|---|---|
| Richard N. Frommer | Interim President, Interim Chief Executive Officer and Director |
| Gregory Patton | Executive Vice President and Chief Financial Officer |
| Bryan Freeman | Executive Vice President of Operations |
| Daniel T. Sweeney | Executive Vice President, General Counsel and Corporate Secretary |
| Louis J. Basenese | Executive Vice President of Market Strategy |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| May 21, 2026 | 144 | Filing |
| May 20, 2026 | EFFECT | Notice of Effectiveness |
| May 14, 2026 | 8-K | Current Report |
| May 14, 2026 | 10-Q | Quarterly Report |
| May 8, 2026 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 23, 2026 | ARS | Filing |
| Apr 23, 2026 | DEFA14A | Additional definitive proxy soliciting materials and Rule 14(a)(12) material |
| Apr 23, 2026 | DEF 14A | Other definitive proxy statements |
| Apr 22, 2026 | 8-K | Current Report |
| Apr 9, 2026 | 8-K | Current Report |